我的訂單
商品收藏
沒有相關(guān)數(shù)據(jù)
篩選出 44 條數(shù)據(jù),請點擊查看商品詳情
Miltefosine
An inhibitor of CCT
Akt1 and Akt2-IN-1
Akt1andAkt2-IN-1是一種有效的變構(gòu)抑制劑,抑制Akt1(IC50=3.5nM)和Akt2(IC50=42nM)。
Recilisib (Ex-RAD)
Recilisib (Ex-RAD) (ON 01210) 是一種輻射防護劑,可激活細胞中的 AKT、PI3K 活性。
K-80003 (TX-803)
K-80003 (TX-803) 是 tRXRα 的有效抑制劑;依賴 Akt 激活和癌細胞生長。
PF-AKT400 (AKT protein kinase inhibitor)
PF-AKT400(AKT 蛋白激酶抑制劑)是一種廣泛選擇性、強效、ATP 競爭性 Akt 抑制劑,對 PKBα 的選擇性高出 900 倍; (IC50=0.5 nM) 比 PKA (IC50=450 nM)。
AKT-IN-1
AKT-IN-1是一種變構(gòu)AKT抑制劑,IC50為1.042μM。
GSK2110183
Afuresertib (GSK2110183) is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2.
Crebanine
An aporphine alkaloid with diverse biological activities
MK-2206 dihydrochloride
MK-2206雙鹽酸鹽是一種口服活性的變構(gòu)Akt抑制劑,用于治療實體腫瘤。
Ipatasertib dihydrochloride (GDC-0068 (dihydrochloride))
A pan-Akt inhibitor
Crosstide
A peptide substrate for Akt
AKT inhibitor VIII
A potent inhibitor of Akt1 and Akt2
Loureirin A
Loureirin A is a flavonoid extracted from the red resin of the herbs of Dracaena cochinchinensis, which is known as Dragon's Blood. Loureirin A inhibits platelet activation by an impairment of PI3K/Akt signaling. Loureirin A inhibits Akt phosphorylation.
Uprosertib hydrochloride
A selective Akt inhibitor
GSK2110183 hydrochloride
GSK2110183 hydrochloride 是 GSK2110183 的結(jié)構(gòu)類似物。
掃一掃加微信